Eisai, Other Drug Makers Join With IT Firms For Genetic-Cancer Research
This article was originally published in PharmAsia News
Executive Summary
A ten-company group of Japan drug makers, including Eisai, and information technology firms plan to work together to develop cancer treatments for patient-specific needs.